Principal Financial Group
AZN icon

Principal Financial Group’s AstraZeneca AZN Stock Holding History

Principal Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Buy
541,187
+54,155
+11% +$10.2M 0.05% 289
2026
Q1 		$96M Sell
487,032
-75,594
-13% -$14.6M 0.05% 290
2025
Q4 		$103M Sell
562,626
-24,805
-4% -$4.35M 0.05% 264
2025
Q3 		$90.1M Sell
587,431
-14,592
-2% -$2.21M 0.05% 305
2025
Q2 		$84.1M Buy
602,023
+2,798
+0.5% +$392K 0.04% 327
2025
Q1 		$88.1M Buy
599,225
+361,195
+152% +$52.3M 0.05% 302
2024
Q4 		$31.2M Buy
+238,030
New +$33.3M 0.02% 630

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Principal Financial Group's AZN Position: Q2 2026 in Review

Principal Financial Group increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $10.2M and bringing the position to 541,187 shares worth $103M. The position accounts for 0.05% of the portfolio, ranked #289.

Principal Financial Group first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $103M in Q4 2025. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Principal Financial Group held 541,187 shares of AstraZeneca worth $103M as of Q2 2026.
  • Principal Financial Group bought 54,155 AstraZeneca shares in Q2 2026, an estimated $10.2M.
  • AstraZeneca made up 0.05% of Principal Financial Group's portfolio in Q2 2026, its #289 holding.
  • Principal Financial Group first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Principal Financial Group's AstraZeneca position peaked at $103M in Q4 2025.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.